Fri, Dec 26, 2014, 9:01 AM EST - U.S. Markets open in 29 mins.

Recent

% | $
Quotes you view appear here for quick access.

Hemispherx Biopharma, Inc. Message Board

  • adeiflig adeiflig Nov 13, 2009 12:19 AM Flag

    Back up to $ 5/sh on speculation alone

    Volume has been very low on these lawsuits, meaning that most people are with HEB and know that lawsuits are a farce, they don't even have a lead plaintiff.

    When HEB announces in mid December 2009 that all items have been submitted to the FDA, then we enter the speculation phase of possible FDA approval, anyday.

    This means that people will begin to buy aggressively and, a run to $ 5 per share on this speculation alone is reasonable.


    When it gets approved, stock will OPEN near the $ 17 to $ 19 range.

    Potential for 360 million doses at say $ 30/dose is a $ 1 billion per year operation. That means stock price valuation is near to $ 60 per share.

    The more attacks you see against HEB, the more negative articles on HEB, the larger the number of bashers only confirms that this is a billion dollar company in the making and they want your shares.

    Buy more shares, average down, when it rallies you will make a killing.

    SortNewest  |  Oldest  |  Most Replied Expand all replies
 
HEB
0.22Dec 24 1:01 PMEST

Trending Tickers

i
Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.
Virgin America Inc.
NASDAQWed, Dec 24, 2014 1:00 PM EST
Gilead Sciences Inc.
NASDAQWed, Dec 24, 2014 1:00 PM EST
Spectrum Pharmaceuticals, Inc.
NASDAQWed, Dec 24, 2014 1:00 PM EST